- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hubei Biocause Pharmaceutical (000627)
Hubei Biocause Pharmaceutical stock price live, this page displays SZ 000627 stock exchange data. View the 000627 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hubei Biocause Pharmaceutical real time stock price chart below.
What Is the Hubei Biocause Pharmaceutical Stock Price Today?
The Hubei Biocause Pharmaceutical stock price today is 1.76.
What Is the Stock Symbol for Hubei Biocause Pharmaceutical?
The stock symbol for Hubei Biocause Pharmaceutical is ""000627.""
What Stock Exchange Does Hubei Biocause Pharmaceutical Trade On?
Hubei Biocause Pharmaceutical is listed and trades on the Shenzhen stock exchange.
Is Hubei Biocause Pharmaceutical a Good Stock to Buy?
Determining whether Hubei Biocause Pharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 000627 quote. (ISIN: CNE000000F48)
What Is the Hubei Biocause Pharmaceutical Stock Price Today?
The Hubei Biocause Pharmaceutical stock price today is 1.76.
What Is the Stock Symbol for Hubei Biocause Pharmaceutical?
The stock symbol for Hubei Biocause Pharmaceutical is ""000627.""
What Stock Exchange Does Hubei Biocause Pharmaceutical Trade On?
Hubei Biocause Pharmaceutical is listed and trades on the Shenzhen stock exchange.
Is Hubei Biocause Pharmaceutical a Good Stock to Buy?
Determining whether Hubei Biocause Pharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 000627 quote. (ISIN: CNE000000F48)
Shenzhen
Currency in CNY
1.76
-0.06(-3.30%)
Closed·
Fair Value
An estimate of a Hubei Biocause Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.73
1.85
52 wk Range
1.64
5.42
000627 Scorecard
Full Analysis
Trading at a low Price / Book multiple
Unusual trading volume
Fair Value
An estimate of a Hubei Biocause Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.731.85
52 wk Range
1.645.42
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
000627 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Hubei Biocause Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell
Hubei Biocause Pharmaceutical Company Profile
Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. It exports its products to approximately 85 countries, including the United States, the European Union, and internationally. The company is based in Jingmen, China.
Compare 000627 to Peers and Sector
Metrics to compare | 000627 | Sector Sector - Average of metrics from a broad group of related Financial sector companies | Relationship Relationship000627PeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.2x | 8.1x | 9.7x | |
PEG Ratio | 0.04 | 0.06 | 0.03 | |
Price/Book | 0.4x | 1.2x | 1.0x | |
Price / LTM Sales | 0.2x | 0.8x | 2.9x | |
Upside (Analyst Target) | - | 1.0% | 9.7% | |
Fair Value Upside | Unlock | 7.8% | 1.4% | Unlock |
Earnings
Latest Release
Oct 30, 2024
EPS / Forecast
0.01 / --
Revenue / Forecast
4.54B / --
FAQ
What Stock Exchange Does Hubei Biocause Pharmaceutical Trade On?
Hubei Biocause Pharmaceutical is listed and trades on the Shenzhen Stock Exchange stock exchange.
What Is the Stock Symbol for Hubei Biocause Pharmaceutical?
The stock symbol for Hubei Biocause Pharmaceutical is "000627."
What Is the Hubei Biocause Pharmaceutical Market Cap?
As of today, Hubei Biocause Pharmaceutical market cap is 8.63B.
What Is Hubei Biocause Pharmaceutical's Earnings Per Share (TTM)?
The Hubei Biocause Pharmaceutical EPS (TTM) is -0.15.
From a Technical Analysis Perspective, Is 000627 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Hubei Biocause Pharmaceutical Stock Split?
Hubei Biocause Pharmaceutical has split 8 times.
How Many Employees Does Hubei Biocause Pharmaceutical Have?
Hubei Biocause Pharmaceutical has 1765 employees.
What is the current trading status of Hubei Biocause Pharmaceutical (000627)?
As of 23 Jul 2025, Hubei Biocause Pharmaceutical (000627) is trading at a price of 1.76, with a previous close of 1.76. The stock has fluctuated within a day range of 1.73 to 1.85, while its 52-week range spans from 1.64 to 5.42.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.